A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Douglas P. Baker net worth and biography

Douglas Baker Biography and Net Worth

CFO of OptimizeRx

Doug joined OptimizeRx as CFO in May 2014. He spent the previous 18 years as CFO of Applied Nanotech Holdings, Inc., a public company specializing in nanotechnology research and development.

Hands-on CFO with excellent strategic vision and strong technical and problem-solving skills.

Specialties/Strengths: SEC Reporting, Registration Statements, Investor Relations, Forecasting and Budgeting, Strategic Planning and Business Planning, Fundraising Structures, Mergers and Acquisitions, Restructuring/Turnarounds, Sarbanes Oxley Compliance, Start-ups, Taxation, Litigation Support, Board of Directors.

What is Douglas P. Baker's net worth?: The estimated net worth of Douglas P. Baker is at least $201,134.04 as of September 14th, 2021. Mr. Baker owns 44,796 shares of OptimizeRx stock worth more than $201,134 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Baker may own. Learn More about Douglas P. Baker's net worth.
How do I contact Douglas P. Baker?: The corporate mailing address for Mr. Baker and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]. Learn More on Douglas P. Baker's contact information.
Has Douglas P. Baker been buying or selling shares of OptimizeRx?: Douglas P. Baker has not been actively trading shares of OptimizeRx during the last ninety days. Most recently, Douglas P. Baker sold 14,000 shares of the business's stock in a transaction on Tuesday, October 5th. The shares were sold at an average price of $82.88, for a transaction totalling $1,160,320.00. Learn More on Douglas P. Baker's trading history.
Who are OptimizeRx's active insiders?: OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), Stephen Silvestro (Insider), and Patrick Spangler (Director). Learn More on OptimizeRx's active insiders.
Are insiders buying or selling shares of OptimizeRx?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $60,760.00. The most recent insider tranaction occured on January, 9th when General Counsel Marion Odence-Ford sold 4,000 shares worth more than $60,760.00. Insiders at OptimizeRx own 6.1% of the company. Learn More about insider trades at OptimizeRx.
Information on this page was last updated on 1/9/2024.

Douglas P. Baker Insider Trading History at OptimizeRx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/5/2021	Sell	14,000	$82.88	$1,160,320.00
9/28/2021	Sell	2,000	$74.66	$149,320.00
9/21/2021	Sell	4,000	$70.59	$282,360.00
9/14/2021	Sell	3,768	$65.57	$247,067.76	44,796
9/8/2021	Sell	10,000	$67.25	$672,500.00	48,564
8/31/2021	Sell	4,000	$66.62	$266,480.00	50,796
8/24/2021	Sell	4,000	$61.50	$246,000.00	58,796
8/20/2021	Sell	5,000	$58.45	$292,250.00
7/27/2021	Sell	3,000	$52.58	$157,740.00	76,796
7/20/2021	Sell	3,000	$50.90	$152,700.00
7/8/2021	Sell	13,435	$56.05	$753,031.75	69,361
6/28/2021	Sell	3,421	$63.00	$215,523.00	82,796
6/24/2021	Sell	4,000	$60.00	$240,000.00	86,217
6/7/2021	Sell	14,500	$52.62	$762,990.00	75,717
5/18/2021	Sell	14,500	$45.85	$664,825.00	75,717
1/29/2021	Sell	5,032	$47.25	$237,762.00	85,902
1/13/2021	Sell	5,000	$38.89	$194,450.00	85,937
11/11/2020	Sell	15,000	$24.05	$360,750.00	75,705
9/2/2020	Sell	10,000	$20.00	$200,000.00	80,705
8/13/2020	Sell	10,000	$18.00	$180,000.00	100,671
8/6/2020	Sell	10,000	$17.01	$170,100.00	100,671
7/16/2020	Sell	6,667	$15.00	$100,005.00	82,671
8/10/2018	Sell	4,784	$12.01	$57,455.84
5/11/2017	Buy	10,000	$0.77	$7,700.00	50,000
11/14/2016	Buy	10,000	$0.85	$8,500.00	40,000
6/7/2016	Buy	10,000	$1.05	$10,500.00	30,000
11/17/2014	Buy	10,000	$0.88	$8,800.00
6/5/2014	Buy	10,000	$1.50	$15,000.00

Douglas P. Baker Buying and Selling Activity at OptimizeRx

OptimizeRx Company Overview

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Today's Range

Now: $4.49

$4.32

$4.50

50 Day Range

MA: $6.41

$3.83

$8.16

2 Week Range

Now: $4.49

$3.78

$16.65

Volume

308,936 shs

Average Volume

147,129 shs

Market Capitalization

$82.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

War on Elon Escalates…

From Porter & Company | Ad